BGS vs. MED, THS, JBSS, SENEA, CVGW, LWAY, HAIN, FARM, MDLZ, and HSY
Should you be buying B&G Foods stock or one of its competitors? The main competitors of B&G Foods include Medifast (MED), TreeHouse Foods (THS), John B. Sanfilippo & Son (JBSS), Seneca Foods (SENEA), Calavo Growers (CVGW), Lifeway Foods (LWAY), The Hain Celestial Group (HAIN), Farmer Brothers (FARM), Mondelez International (MDLZ), and Hershey (HSY).
B&G Foods vs. Its Competitors
Medifast (NYSE:MED) and B&G Foods (NYSE:BGS) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.
Medifast has a net margin of 0.76% compared to B&G Foods' net margin of -12.02%. B&G Foods' return on equity of 7.16% beat Medifast's return on equity.
95.5% of Medifast shares are owned by institutional investors. Comparatively, 66.2% of B&G Foods shares are owned by institutional investors. 2.9% of Medifast shares are owned by insiders. Comparatively, 3.2% of B&G Foods shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Medifast has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, B&G Foods has a beta of 0.48, indicating that its share price is 52% less volatile than the S&P 500.
Medifast pays an annual dividend of $6.60 per share and has a dividend yield of 51.0%. B&G Foods pays an annual dividend of $0.76 per share and has a dividend yield of 18.9%. Medifast pays out 2,062.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. B&G Foods pays out -26.9% of its earnings in the form of a dividend.
In the previous week, B&G Foods had 3 more articles in the media than Medifast. MarketBeat recorded 22 mentions for B&G Foods and 19 mentions for Medifast. Medifast's average media sentiment score of 0.26 beat B&G Foods' score of 0.04 indicating that Medifast is being referred to more favorably in the media.
Medifast presently has a consensus price target of $16.50, indicating a potential upside of 27.56%. B&G Foods has a consensus price target of $6.10, indicating a potential upside of 51.55%. Given B&G Foods' higher possible upside, analysts clearly believe B&G Foods is more favorable than Medifast.
Medifast has higher earnings, but lower revenue than B&G Foods. B&G Foods is trading at a lower price-to-earnings ratio than Medifast, indicating that it is currently the more affordable of the two stocks.
Summary
Medifast beats B&G Foods on 11 of the 17 factors compared between the two stocks.
Get B&G Foods News Delivered to You Automatically
Sign up to receive the latest news and ratings for BGS and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding BGS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
B&G Foods Competitors List
Related Companies and Tools
This page (NYSE:BGS) was last updated on 8/8/2025 by MarketBeat.com Staff
